Please login to the form below

Not currently logged in
Email:
Password:

Nuvigil

This page shows the latest Nuvigil news and features for those working in and with pharma, biotech and healthcare.

Teva halts development of Nuvigil in bipolar disorder

Teva halts development of Nuvigil in bipolar disorder

Nuvigil made $347m for Teva during 2012 in these indications, but the company was keen to expand its use ahead of patent expiry in 2016. ... Any further plans to expand the use of the product now seem unlikely, with Dr Hayden commenting: “We will

Latest news

  • Teva suffers setback as Nuvigil fails late-stage trial Teva suffers setback as Nuvigil fails late-stage trial

    Disappointing results in treating bipolar disorder but drug development continues. Teva's Nuvigil has failed to show efficacy in a phase III trial in bipolar disorder, although the pharma company insists ... Some analysts believe the availability of

  • Cephalon jet lag application rejected

    Cephalon has dropped its bid to get sleep disorder drug Nuvigil approved as a treatment for jet lag after a second rejection from the US FDA. ... Cephalon stressed that Nuvigil met the primary endpoints of pivotal studies comparing the drug to placebo.

  • Cephalon posts record sales

    The quarter also saw Cephalon launch Nuvigil tablets and file a supplemental new drug application with the US Food and Drug Administration (FDA) for the drug as a treatment for excessive ... If Nuvigil is approved it will be the first acute indication

  • State of mind

    Acute mania. MEM 1003. Bayer. Acute mania. Armodafinil. Nuvigil; Cephalon. Bipolar disorder. ... Armodafinil (Nuvigil, Cephalon) is currently being investigated as a therapy for bipolar disorders.

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics